Abstract
A prospective examiner-blind, cross-over study was conducted to compare the efficacy of memantine (40 or 60 mg/day) and gabapentin (1,200 mg/day) as therapy for acquired fixational pendular nystagmus (APN) in 11 patients with multiple sclerosis. APN was documented in 20 eyes by electrooculography (EOG). The primary objective of the study was an at least 50% reduction in amplitude and/or frequency of APN compared with baseline values in EOG. This aim was reached for 17 of 20 APN-affected eyes with memantine 40–60 mg and for 11 eyes with gabapentin up to 1,200 mg. A complete cessation of APN was achieved in eight eyes (four patients) with memantine 40 mg and in a further four eyes (two patients) with memantine 60 mg. One patient achieved the same benefit with memantine 40 mg and gabapentin. In two other eyes APN completely subsided with gabapentin 1,200 mg only, but not with memantine. Near visual acuity, a secondary outcome parameter, improved by at least 0.1 in 11 of 17 eyes treated with memantine and in 8 out of 16 eyes treated with gabapentin. In summary, memantine and gabapentin are safe and effective treatment options for APN.
Similar content being viewed by others
References
Averbuch-Heller l, Zivotofsky AZ, Das VE, DiScenna AO, Leigh RJ (1995) Investigations of the pathogenesis of acquired pendular nystagmus. Brain 118:369–378
Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, Büttner U, Leigh RJ (1997) A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 41:818–825
Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C (2001) Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry 71:107–110
Barton JJS, Huaman AG, Sharpe JA (1994) Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 35:319–325
Bormann J (1989) Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591–592
Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229:75–82
Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warrach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427–4436
Currie J, Matsuo V (1986) The use of clonazepam in the treatment of nystagmus induced oscillopsia. Ophthalmology 93:924–932
Dahl JB, Mathiesen O, Moiniche S (2004) ‘Protective premedication’: an option with gabapentin and related drugs? A review of gabapentin and pregabalin in in the treatment of post-operative pain. Acta Anaesthesiol Scand 48:1130–1136
Dieterich M, Straube A, Brandt Th, Paulus W, Büttner U (1991) The effects of baclofen and anticholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 5:627–632
Dieterich M (2002) The topographic diagnosis of acquired nystagmus in brainstem disorders. Strabismus 10:137–145
Ell JJ, Gresty MA, Chambers BR, Findley LJ (1982) Acquired pendular nystagmus: characteristics, pathophysiology and pharmacological modification. In: Roucoux A, Crommelinck M (eds) Physiological and pathological aspects of eye movements. Dr Junk Publishers, The Hague, pp 89–98
Gresty MA, Ell JJ, Findley LJ (1982) Acquired pendular nystagmus: its characteristics, localizing value and pathophysiology. J Neurol Neurosurg Psychiatry 45:431–439
Helveston EM, Pogrebniak AE (1988) Treatment of acquired nystagmus with botulinum toxin A. Am J Ophthalmol 106:584–586
Helveston EM, Ellis FD, Plager DA (1991) Large recession of the horizontal recti for treatment of nystagmus. Ophthalmology 98:1302–1305
Herishanu Y, Louzoun Z (1986) Trihexyphenidyl treatment of vertical pendular nystagmus. Neurology 3:82–84
Inobe J, Arakawa T, Mori T, Kumamoto T, Tsuda T (2000) Acquired pendular nystagmus associated with the lesion of tegmentum mesencephali in a patient with probable multiple sclerosis. Rinsho Shinkeigaku 40:1012–1017
Jabbari B, Rosenberg M, Scherokman B, Gunderson C, McBurney JW, McClintock W (1987) Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 2:93–98
Jain S, Proudlock F, Constantinescu CS, Gottlob I (2002) Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol 134:780–782
Kim JI, Averbuch-Heller L, Leigh RJ (2001) Evaluation of transdermal scopolamine as treatment for acquired nystagmus. J Neuroophthalmol 21:188–192
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Leigh RJ, Zee DS (1991) The neurology of eye movements, 2nd edn. FA Davis, Philadelphia
Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ (1991) The effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology 41:1737–1741
Leigh RJ, Tomsak RL, Grant MP, Remler BF, Yaniglos SS, Lystad L, Dell’Osso LF (1992) Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 32:633–642
Leigh J, Averbuch-Heller L, Tomsak RL, Remler BF, Yaniglos SS, Dell’Osso LF (1994) Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology. Ann Neurol 36:129–141
Leigh RJ, Das VE, Seidman SH (2002) A neurobiological approach to acquired nystagmus. Ann N Y Acad Sci 956:380–390
Lefkowitz D, Harpold G (1985) Treatment of ocular myoclonus with valproic acid. Ann Neurol 17:103–104
Lopez LI, Bronstein AM, Gresty MA, DuBoulay EP, Rudge P (1996) Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain 119:465–472
Lossignol DA, Plehiers B, Body JJ (2004) Gabapentin (Neurontin) and cancer pain: a pilot study. Rev Med Brux 25:429–435
Menon GJ, Thaller VT (2002) Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin—an effective treatment for acquired nystagmus with oscillopsia. Eye 16:804–806
Mettes P, Godaux E, Cheron G, Galiana HL (1994) Effect of muscimol microinjections into the prepositus hypoglossi and the medial vestibular nuclei on cat eye movements. J Neurophysiol 72:785–802
Mossman SS, Bronstein AM, Rudge P, Gresty MA (1985) Acquired pendular nystagmus suppressed by alcohol. Neuroophthalmology 13:99–106
Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 33:403–407
Poser CM, Paty DW, Scheinberg LC, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Schon F, Hart P, Hodgson T, Pambakian A, Kennard C (1999) Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 54:2190–2191
Shery T, Proudlock FA, Sarvananthan N, McLean RJ, Gottlob I (2006) The effects of gabapentin and memantine in acquired and congenital nystagmus—a retrospective study. Br J Ophthalmol 90:839–843
Smith RM, Oommen BS, Stahl JS (2004) Application of adaptive filters to visual testing and treatment in acquired pendular nystagmus. J Rehabil Res Dev 41:313–324
Smith RM, Oommen BS, Stahl JS (2004) Image-shifting optics for a nystagmus treatment device. J Rehabil Res Dev 41:325–336
Stahl JS, Lehmkuhle M, Wu K, Burke B, Saghafi D, Pesh-Imam S (2000) Prospects for treating acquired pendular nystagmus with servo-controlled optics. Invest Ophthalmol Vis Sci 41:1084–1090
Stahl JS, Leigh RJ (2001) Nystagmus. Curr Neurol Neurosci Rep 1:471–477
Starck M, Albrecht H, Pöllmann W, Straube A, Dieterich M (1997) Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 244:9–16
Straube A, Paulus W, Quintern J, Brandt Th (1989) Visual ataxia induced by eye movements: posturographic measurements in normals and patients with ocular motor disorders. Clin Sci 4:107–113
Straube A, Leigh RJ, Bronstein A, Heide W, Riordan-Eva P, Tijssen CC, Dehaene I (2004) EFNS task force–therapy of nystagmus and oscillopsia. Eur J Neurol 11:83–89
Traccis S, Rosati G, Monaco M, Aiello I, Agnetti V (1990) Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 40:492–494
Yokota J, Kosaka K, Yoshimoto Y, Amakusa T (1999) Acquired pendular nystagmus after pontine hemorrhage. No To Shinkei 51:1055–1060
Acknowledgments
We thank Ms. J. Benson for copy-editing the manuscript
Conflict of interest statement
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Starck, M., Albrecht, H., Pöllmann, W. et al. Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol 257, 322–327 (2010). https://doi.org/10.1007/s00415-009-5309-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5309-x